Qian Wang

Qian Wang

Auto-generated profile, based on publicly available information

Qian Wang

School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2018 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
QWQian Wang
Qian Wang
HZHui Zhang
Hui Zhang
HGHongquan Gan
Hongquan Gan
HWHui Wang
Hui Wang
QLQijia Li
Qijia Li
ZWZhiqiang Wang
Zhiqiang Wang

7 August 2015 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
XWXiaowei Wu
Xiaowei Wu
QWQian Wang
Qian Wang
NKNing Kang
Ning Kang
JWJingguo Wu
Jingguo Wu
CGCongmin Gu
Congmin Gu
RXRan Xiao
Ran Xiao
Bone repair using tissue‐engineered bone (TEB) in a large defect or accompanied by a poor recipient vascular bed is a long‐standing challenge. Surgical vascular carrier patterns of vascular bundle (VB) and arteriovenous loop (AV loop) have been shown to improve the vascularization and repair capacity of TEB. However, the effects of these different vascular carrier patterns on angiogenesis and osteogenesis in TEB have never been evaluated. Here, TEB was constructed with bone marrow mesenchymal stem cells (BMSCs) and β‐TCP and prevascularized by the VB or AV loop technique in beagle dogs. The vascularization and bone formation in TEB were quantitatively compared using Microfil perfusion, histological examination and CT and micro‐CT analyses. The distribution and constitution of the neovasculature were analysed to determine the underlying mechanism of angiogenesis. The results showed that prevascularized TEB generated bone tissue faster and more homogeneously than untreated TEB. The VB technique was found to strike a better balance between bone regeneration and β‐TCP scaffold degradation than the AV loop strategy, which resulted in more vascularization but less bone yield, due to faster degradation of the β‐TCP scaffold. This study indicates that a suitable triangular relationship, composed of bone regeneration, scaffold degradation and vasculature, is critical to TEB construction. Copyright © 2015 John Wiley & Sons, Ltd.

15 May 2025 in Biochemical Pharmacology
Verified
Journal Article
Closed access
FJFan Jiaxin
Fan Jiaxin
JXJia Xiang
Jia Xiang
CYCui YongPing
Cui YongPing
LKLiu Kainan
Liu Kainan
XTXu Tianjie
Xu Tianjie
WQWang Qian
Wang Qian

26 June 2025 in Cell and Tissue Banking
Verified
Journal Article
Closed access
PDF file
SLSiyu Li
Siyu Li
XJXiang Jia
Xiang Jia
YCYongping Cui
Yongping Cui
KLKainan Liu
Kainan Liu
TXTianjie Xu
Tianjie Xu
QWQian Wang
Qian Wang

24 August 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YCYongping Cui
Yongping Cui
XGXiaoling Guo
Xiaoling Guo
JXJingqi Xu
Jingqi Xu
XJXiang Jia
Xiang Jia
JFJiaxin Fan
Jiaxin Fan
QWQian Wang
Qian Wang
Parkinson's disease (PD) is a common neurodegenerative disorder with a complex pathogenesis linked to ferroptosis, apoptosis, inflammation, and oxidative stress. Mounting evidence has demonstrated that the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway is deeply involved in PD pathogenesis and acts as a key regulator of ferroptosis. Crocin, a carotenoid from saffron, exhibits potent neuroprotective effects in neurodegenerative diseases, particularly its anti-ferroptotic activity, alongside anti-apoptotic, anti-inflammatory, and antioxidant properties, though its precise molecular mechanisms remain unclear. Against this background, the present study aimed to explore the regulatory role of the mTOR pathway in rotenone (ROT)-induced ferroptosis and PD progression in rats, and to further investigate whether crocin exerts neuroprotection by targeting this signaling pathway and inhibiting ferroptosis. Male Sprague–Dawley rats were randomized into control, ROT, and Crocin + ROT groups. The ROT group received subcutaneous ROT (1.5 mg/kg/day) for 21 days to induce chronic PD; the Crocin + ROT group was gavaged with crocin (30 mg/kg) 2 h before each ROT injection. Subsequently, behavioral performance (open field, rotarod, and balance beam tests), striatal dopamine, reactive oxygen species (ROS), and 4-hydroxynonenal (4-HNE) levels (enzyme-linked immunosorbent assay, ELISA), substantia nigra (SN) histopathology (hematoxylin–eosin and Nissl staining), tyrosine hydroxylase (TH) immunohistochemistry, mitochondrial ultrastructure (transmission electron microscopy), glutathione (GSH), malondialdehyde (MDA), and Fe2⁺ levels, and AKT/mTOR-related protein expression (Western blotting) were assessed. ROT induced motor dysfunction, reduced striatal dopamine levels, reduced TH-positive neurons in the SN, caused ferroptosis-like mitochondrial ultrastructural alterations, disrupted redox and iron homeostasis, and dysregulated the AKT/mTOR pathway (P < 0.05). Crocin intervention significantly reversed these changes (P < 0.05). Collectively, these findings suggest that crocin exerts neuroprotective effects in ROT-induced PD rats, possibly through modulation of the AKT/mTOR pathway and attenuation of ferroptosis and apoptosis.